Sean A. McCarthy - Dec 20, 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Stock symbol
CTMX
Transactions as of
Dec 20, 2023
Transactions value $
-$18,710
Form type
4
Date filed
12/22/2023, 04:16 PM
Previous filing
Dec 19, 2023
Next filing
Jan 19, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$18.7K -13.6K -2.89% $1.38 455K Dec 20, 2023 Direct F1, F2
holding CTMX Common Stock 93.2K Dec 20, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
F2 Includes 161,250 restricted stock units.
F3 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.